Michael Leuchten

Stock Analyst at UBS

(2.57)

# 2,192

Out of 4,732 analysts

9

Total ratings

71.43%

Success rate

9.72%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Michael Leuchten

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Downgrades: Sell	n/a	$78.69	-	4	Jun 28, 2022
	AZN AstraZeneca	Upgrades: Buy	n/a	$66.60	-	4	Feb 25, 2021
	SNY Sanofi	Downgrades: Underweight	n/a	$50.74	-	1	Jan 23, 2018

Novo Nordisk

Jun 28, 2022

Downgrades: Sell

Price Target: n/a

Current: $78.69

Upside: -

AstraZeneca

Feb 25, 2021

Upgrades: Buy

Price Target: n/a

Current: $66.60

Upside: -

Sanofi

Jan 23, 2018

Downgrades: Underweight

Price Target: n/a

Current: $50.74

Upside: -